About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Houston | 1,199 Studies

Clinical Trials Breast CancerHouston

Breast Cancer Clinical Trials in Houston

Find 1,199 clinical trials for breast cancer near Houston, Texas. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1181-1199 of 1,199 trials

CompletedT-DM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast CancerThis open-label, single-center Phase Ib study will assess the safety and tolerability of combining trastuzumab emtansine (T-DM1) with Lapatinib and Abraxane in patients with…NCT02073916·Houston, Texas UnknownOctavaPink for Women With Dense Breast After Negative MammographyThe OctavaPink test is indicated as an adjunct to mammography for breast cancer screening in asymptomatic women for whom screening or diagnostic mammography findings are normal or…NCT02209389·Detroit, Michigan and 6 others CompletedRandomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase InhibitorThe purpose of this study is to find out what effect the combination of fulvestrant (Faslodex) and dasatinib (Sprycel) has on advanced breast cancer compared to fulvestrant alone.NCT00754325·Sedona, Arizona and 27 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedStudy of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer SurvivorsThis randomized phase II trial studies how well docosahexaenoic acid works in preventing recurrence in breast cancer survivors.NCT01849250·Boston, Massachusetts and 3 others

CompletedHarvest of CTCs From MBC Patients Using the Parsortix™ PC1 SystemThe purpose of this clinical study is to demonstrate that the Parsortix™ PC1 system enables the capture and harvest of circulating tumor cells (CTCs) from the peripheral blood of…NCT03427450·Los Angeles, California and 3 others

TerminatedAmcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast CancerPrimary Objective: To determine whether Amcenestrant (SAR439859) in combination with palbociclib improves progression free survival (PFS) when compared with letrozole in…NCT04478266·Daphne, Alabama and 248 others

CompletedA Study of ZYC300 Administered With Cyclophosphamide Pre-DosingThe purpose of this study is to evaluate the feasibility, safety, and tolerability of administering ZYC300 with Cyclophosphamide (Cytoxan).NCT00381173·Boston, Massachusetts and 1 other

TerminatedEvaluation of Mammographic Breast Density in Participants with Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502This phase III trial evaluates mammographic breast density in participants with hormone receptor-negative breast cancer enrolled on study A011502.NCT03609021·Fairbanks, Alaska and 514 others

TerminatedOpen-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesThe purpose of the Study is to select a dose and assess the safety and tolerability of INCB057643 as a monotherapy (Part 1 and Part 2) and in combination with standard-of-care…NCT02711137·Birmingham, Alabama and 17 others

RecruitingFirst-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid TumorsStudy STX-478-101 (LY4064809) is a multipart, open-label, phase 1/2 study evaluating the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of STX-478…NCT05768139·Los Angeles, California and 64 others

TerminatedSafety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast CancerThis study will determine the highest dose of KW-2450 in combination with lapatinib and letrozole that can be administered safely to subjects with advanced or metastatic breast…NCT01199367·Long Beach, California and 4 others

RecruitingA Study of Sigvotatug Vedotin in Advanced Solid TumorsThis trial will look at a drug called sigvotatug vedotin (SGN-B6A) alone and with pembrolizumab, with or without chemotherapy, to find out whether it is safe for people who have…NCT04389632·Anchorage, Alaska and 157 others

CompletedLetrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast CancerThis phase II trial studies the side effects and how well letrozole and imatinib mesylate work in treating postmenopausal participants with estrogen or progesterone positive…NCT00338728·Houston, Texas

Active not recruitingRadiation Therapy in Treating Patients With Stage 0-II Breast CancerThis phase II trial studies the side effects and how well radiation therapy works in treating patients with stage 0-II breast cancer.NCT01245712·Houston, Texas

CompletedEarly Detection and Prediction of Chemotherapy Induced Cardiac Toxicity in Breast Cancer PatientsThe goal of this clinical research study is to learn whether different ways of viewing echocardiogram pictures along with blood tests can help to see heart-related side effects of…NCT00806507·Boston, Massachusetts and 1 other

CompletedS9832: Effectiveness of Telephone Counseling By Breast Cancer Survivors on the Well-Being of Women With Recurrent Breast CancerRATIONALE: Telephone counseling by breast cancer survivors may enhance the well-being and quality of life of women who have recurrent breast cancer.NCT00031772·Birmingham, Alabama and 108 others

TerminatedFT516 in Combination With Monoclonal Antibodies in Advanced Solid TumorsThis is a Phase 1 dose-finding study of FT-516 in combination with monoclonal antibodies in participants with advanced solid tumors.NCT04551885·Minneapolis, Minnesota and 2 others

CompletedSafety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast CancerThis is a Phase Ib, open-label, two-stage study with two active regimens in each stage designed to evaluate the safety and tolerability of combination treatment with atezolizumab…NCT02605915·Birmingham, Alabama and 19 others

TerminatedA Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002)This is a study evaluating the efficacy, safety, and pharmacokinetics of zilovertamab vedotin in participants with metastatic solid tumors including previously treated cancers of…NCT04504916·Hollywood, Florida and 13 others

PreviousPage 60 of 60

Other Conditions in Houston

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma